Back to the directory

Notable Labs

Personalized drug discovery for blood cancer.

Founded
2014
Status
Public
Stage
Growth
Team size
40
Location
San Francisco, CA, USA; Foster City
Category
Biotech & Drug Discovery
Sector
Diagnostics

About Notable Labs

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers

BiotechDrug discoveryOncology

Clinical trials

1 registered trial with this company as lead sponsor, 2019.

Status
Completed (1)
Conditions
Acute Myelogenous Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Lymphoblastic Leukemia

NCT04014764

Source: ClinicalTrials.gov.

Securities filings

6 Form D filings on record, 2016 to 2023.

Filed as Notable Labs, Inc.

CIK 0001674834

Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.

Company data compiled and maintained by Healthcare Discovery.